Eli Lilly (LLY.US) stops muscle protective drug diabetes research, Zepbound combination plan affected.

date
25/09/2025
Zhitong Finance APP learned that pharmaceutical giant Eli Lilly (LLY.US) has halted experimental drug research aimed at preventing muscle loss in obese patients, citing strategic business considerations.
Latest
See all latestmore